asa guidelines semaglutide GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review PERIOPERATIVE GLP-1: ASA vs. GASTROENTEROLOGISTS

Until Phase 3 data are available, and particularly until head-to-head comparisons and cardiovascular outcomes trials are completed, retatrutide's apparent advantages remain preliminary and unconfirmed

Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes

Fertility planning

Mitchell AGM-C, A

With the growing popularity of weight loss medications like Wegovy, which is a GLP-1 receptor agonist, understanding how these medications affect hunger becomes increasingly important

For weekly medications, choosing a day that aligns with regular activities can improve adherence